# Controlled Internal Convection in Low Flow Hemodialysis of Dialysate: Removal of Beta-2-microglobulin

> **NCT05419271** · NA · UNKNOWN · sponsor: **University Hospital, Caen** · enrollment: 16 (estimated)

## Conditions studied

- Daily Home Hemodialysis

## Interventions

- **PROCEDURE:** home hemodialysis session with 9L internal convection

## Key facts

- **NCT ID:** NCT05419271
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-09
- **Primary completion:** 2022-06
- **Final completion:** 2022-09
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05419271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05419271, "Controlled Internal Convection in Low Flow Hemodialysis of Dialysate: Removal of Beta-2-microglobulin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05419271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*